Alpine Woods Capital Investors, LLC Alpine Immune Sciences, Inc. Transaction History

Alpine Woods Capital Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$2.77 - $12.1 $29,306 - $128,018	-10,580 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$2.45 - $3.87 $10,829 - $17,105	-4,420 Reduced 29.47%	10,580 $41,000
Q2 2018 Aug 09, 2018	BUY	$7.16 - $10.05 $35,800 - $50,250	5,000 Added 50.0%	15,000 $114,000
Q4 2017 Feb 14, 2018	BUY	$9.65 - $12.65 $96,500 - $126,500	10,000	10,000 $112,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.